India aims at U.S. FDA standards on drugs with name change afoot
13 July 2015
Indian policymakers say one way to break the cycle of repeated manufacturing violations that freeze drugmakers out of the U.S. market is to adopt U.S. FDA rules wholesale domestically--and that may happen soon.
10 July 2015
Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced Glenn Noronha, PhD, executive vice president of Research and Development of Clearside, will present at the 2015 International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) Clinical meeting in Berlin, Germany on Friday, July 10. Dr. Noronha’s presentation“Using suprachoroidal administration as an approach to treat noninfectious uveitis – from concept through clinical data” will be part of the afternoon Drug Delivery session.
Russian researchers develop next gen cardiograph scanning
10 July 2015
The Russian Quantum Center (RQC) is developing ultrasensitive sensors based on monocrystal garnet ferrite film to diagnose possible infarction developments in a patient, RQC announced .
US Capital Markets Will Continue to Lure European Biotech
10 July 2015
US capital markets will continue to lure European biotechs, according to BioPharm Insight. In 2012, only ten biotechs listed on the NASDAQ, but in 2013 there were 41, rising again to 73 in 2014 (Mergermarket ECM data).
10 July 2015
The FDA program to expedite the development and approval of innovative drugs for serious and life-threatening conditions is a great success, but determining whether an experimental compound has real transformative potential is proving to be a challenge for sponsors and for the agency.
The Challenge of Forecasting Biosimilars
09 July 2015
The introduction of biologic medicines revolutionized treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases. The landscape for biologics will change dramatically in the next decade as many products – more than $60 billion in worldwide sales – lose their market exclusivity. In response, many companies are striving to bring similar biologic products, or “biosimilars,” to the market to capitalize on the innovator’s loss of exclusivity.
Molecular device could identify pathogens earlier and more precisely
09 July 2015
Precision medicine, deemed a national priority by President Obama earlier this year, promises to help to ease the burden of antibiotic resistance through diagnostics that will more accurately identify the specific pathogen underlying disease. Now, researchers have developed a new technique that could enable an earlier and more accurate identification of the presence of a particular bacteria, virus or fungus even when the infection remains only in the respiratory or gastrointestinal tract.
Clinical cancer research gets a boost from Japan's cabinet
09 July 2015
Clinical cancer research got a boost in Japan as the cabinet called for faster development of a patient registry from the National Cancer Center and 5 affiliated clinics as part of economic reforms aimed at lifting the country out of decades of deflation, the Japan Times said.
Alibaba Health plans wider online sales push in China as competition heats up
08 July 2015
Alibaba Group Holdings ($BABA) aims for a controlling stake in HK-listed Alibaba Health Information Technology as it seeks to grow in a still-fragmented market in China for online drug sales that increasingly looks like a tough nut to crack as competition grows and regulatory approvals drag, theSouth China Morning Post reports.
Insurer M&A endangers pharma's pricing power, particularly in cancer: Moody's
08 July 2015
Drugmakers can't be excited about the wave of consolidation going through the health insurance business. After all, pharma knows firsthand how mergers can put the screws to prices; just think of Express Scripts ($ESRX) and its Medco buyout.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024